Sarcoidosis Can Cause 6th Nerve Palsy
Yes, sarcoidosis can cause 6th nerve palsy as a manifestation of neurosarcoidosis, though it is a relatively uncommon presentation. 1, 2, 3
Neurosarcoidosis and Cranial Nerve Involvement
Sarcoidosis is a multisystem inflammatory disorder characterized by non-caseating granulomas that can affect virtually any organ system, including the nervous system. Neurosarcoidosis occurs in approximately 5-20% of sarcoidosis patients 1 and can involve:
- The cranial nerves (most common neurological manifestation)
- Brain parenchyma
- Leptomeninges
- Peripheral nerves
While the 7th cranial nerve (facial nerve) is the most frequently affected cranial nerve in neurosarcoidosis 4, the 6th cranial nerve can also be involved, leading to:
- Horizontal diplopia (double vision)
- Impaired abduction of the affected eye
- Compensatory head turn toward the affected side
- Incomitant horizontal misalignment 1
Diagnostic Considerations
When evaluating a patient with 6th nerve palsy, it's important to consider sarcoidosis in the differential diagnosis, especially when:
- The palsy is persistent beyond 6 months (vasculopathic causes typically resolve within this timeframe) 1
- There are other neurological or systemic manifestations of sarcoidosis
- Imaging shows enhancing lesions in the cavernous sinus or along the course of the 6th nerve 3
- The patient has known sarcoidosis in other organ systems
Diagnostic Approach for Suspected Neurosarcoidosis
Neuroimaging: MRI with gadolinium enhancement may show:
- Enhancing lesions in the cavernous sinus
- Leptomeningeal enhancement
- Parenchymal lesions 3
Systemic evaluation:
- Chest imaging (X-ray, CT) to look for hilar lymphadenopathy
- Laboratory tests: ACE levels, calcium levels, vitamin D metabolism 1
- Biopsy of accessible lesions (typically non-neural tissue) to demonstrate non-caseating granulomas
Exclusion of other causes:
- Vasculopathic (diabetes, hypertension)
- Neoplastic
- Traumatic
- Increased intracranial pressure
- Demyelinating diseases 1
Treatment of Neurosarcoidosis with 6th Nerve Palsy
First-line Treatment
- High-dose glucocorticoids: Strongly recommended as initial therapy for all patients with clinically significant neurosarcoidosis, including cranial nerve palsies 1, 5
- Typical regimen: Prednisone/prednisolone 20mg daily or higher, depending on severity
Second-line Treatment
- Methotrexate: Should be added if there is continued disease activity despite glucocorticoid treatment 1, 5
- Dosing: 10-15 mg once weekly
- Has been shown to significantly reduce neurosarcoidosis relapse rates (HR 0.47,95% CI 0.25–0.87; p=0.02) 5
Third-line Treatment
- Infliximab: Should be considered for patients who have continued disease despite glucocorticoids and methotrexate 1, 5
Alternative Agents
- Azathioprine: Can be considered if methotrexate is not tolerated 5
- Mycophenolate mofetil: Less effective than methotrexate (higher relapse rate) 5
- Cyclophosphamide: Reserved for refractory cases due to its side effect profile 5, 4
Monitoring and Follow-up
- Regular neurological examinations
- Follow-up MRI to assess treatment response
- Monitoring for medication side effects, particularly from long-term steroid use:
- Diabetes
- Hypertension
- Osteoporosis
- Cataracts and glaucoma 5
Prognosis
The prognosis for 6th nerve palsy in neurosarcoidosis varies:
- Some cases may resolve spontaneously 3
- Most respond well to appropriate immunosuppressive therapy
- Early treatment is essential to prevent irreversible neurological damage 5
- Prolonged therapy (>1 year) is often required 5
Clinical Pearls and Pitfalls
- Pearl: Consider neurosarcoidosis in cases of persistent or recurrent cranial nerve palsies, especially when multiple cranial nerves are involved or there are other systemic symptoms.
- Pitfall: Neurosarcoidosis can mimic other conditions like meningiomas on imaging, leading to misdiagnosis 3.
- Pearl: While 7th nerve palsy is the most common cranial nerve manifestation of neurosarcoidosis, any cranial nerve can be affected, including the 6th nerve.
- Pitfall: Isolated neurosarcoidosis without systemic manifestations can occur, making diagnosis challenging 6.